GVHD and GFRS in patients with AML undergoing allogeneic transplantation with treosulfan- versus busulfan-based conditioning: a subgroup analysis of the randomized phase III MC-FludT.14/L trial

F. Stoelzel,M. Stelljes,D. Beelen,M. Markiewicz,P. Remenyi,P. Dreger,F. Ciceri,E. M. Wagner-Drouet,C. Junghanss,C. Scheid,F. Patriarca,G. Socie,I. Hilgendorf,A. Rambaldi,K. Schaefer-Eckart,D. Russo,G. U. Grigoleit,G. Wulf,N. Basara,B. Glass,H. Labussiere-Wallet,G. Stuhler,M. Bieniaszewska,J. Casper,E. Holler,F. Benedetti,A. P. Iori,R. Trenschel,W. Bethge

BONE MARROW TRANSPLANTATION（2022）

Cited 0|Views14
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined